Michael Egholm
CIK 1559779 · President & CEO · last filed 2026-05-22
Michael Egholm is a President & CEO who has filed 40 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing shows the insider had shares withheld for taxes covering $97.6K of LAB on May 22, 2026. Across all open-market trades the lifetime net is −$3.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.86M
3
40
-$3.25M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LAB | President & CEO | 6,597,956 | $0.89 | $5.86M | -$15.1K | 20 | 2026-05-22 |
| IsoPlexis Corp (ISO) Delisted | Director | — | $0.76 | — | $0 | 1 | 2022-06-21 |
| PALL CORP (PLL) Delisted | President, BioPharmaceuticals | 0 | $7.25 | $0 | -$3.23M | 19 | 2015-08-31 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | LAB | Tax (F) | −97,626 | -$97.6K | EDGAR |
| 2026-04-08 | LAB | Mixed | +1,143,872 | -$86.3K | EDGAR |
| 2026-02-24 | LAB | Tax (F) | −66,127 | -$76.0K | EDGAR |
| 2025-11-24 | LAB | Tax (F) | −63,529 | -$81.3K | EDGAR |
| 2025-08-22 | LAB | Tax (F) | −54,919 | -$69.7K | EDGAR |
| 2025-08-05 | LAB | Grant (A) | +3,000,000 | $0 | EDGAR |
| 2025-05-30 | LAB | Tax (F) | −9,906 | -$10.8K | EDGAR |
| 2025-05-28 | LAB | Sell (S) | −5,473 | -$5.2K | EDGAR |
| 2025-05-27 | LAB | Sell (S) | −5,116 | -$5.1K | EDGAR |
| 2025-05-22 | LAB | Mixed | −23,062 | -$24.1K | EDGAR |